MYCOTOPIA THERAPIES, INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORSSubscription Agreement • January 6th, 2022 • Mycotopia Therapies, Inc. • Wholesale-groceries, general line • Nevada
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.
EXECUTIVE CONSULTING AGREEMENTExecutive Consulting Agreement • January 14th, 2022 • Mycotopia Therapies, Inc. • Wholesale-groceries, general line • Florida
THIS EXECUTIVE CONSULTING AGREEMENT (the “Agreement”), is entered into as of November 17, 2021 and effective as of the 19th day of January 2021, being the date upon which Consultant was appointed as CEO, is by and between on the one hand, Mycotopia Therapies, Inc., a Nevada corporation, with a headquarters address of 18851 NE 29th Avenue Suite 700, Miami, FL 33180 (the “Company”) and on the other hand, Benjamin Kaplan, an individual (“Consultant”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG PSLY.COM, INC. (“PARENT”), MYCOTOPIA THERAPIES INC. (“MTI”), SILLY MERGER SUB M INC. (“MERGER SUB M”), SILLY MERGER SUB E INC. (“MERGER SUB E”), AND EI.VENTURES, INC. (“EVI”) DATED AS OF MAY ___, 2022Agreement and Plan of Merger • May 19th, 2022 • Mycotopia Therapies, Inc. • Wholesale-groceries, general line • Delaware
TERMINATION OF AGREEMENT AND PLAN OF MERGERTermination of Agreement and Plan of Merger • February 22nd, 2023 • Mycotopia Therapies, Inc. • Medicinal chemicals & botanical products • Delaware
THIS TERMINATION OF AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of this _____day of February, 2023, by and among:
EXCHANGE AGREEMENTExchange Agreement • August 21st, 2024 • Mycotopia Therapies, Inc. • Medicinal chemicals & botanical products
This Exchange Agreement (the “Agreement”) is made this 29th day of July , 2024 by and between EHAVE INC., an Ontario corporation (the “Holder”) and MYCOTOPIA THERAPIES INC., a Nevada corporation (the “Company”)
AGREEMENT FOR PURCHASE OF MARKON BRANDED AND BRAND APPROVED PRODUCTAgreement for Purchase • April 15th, 2019 • 20/20 Global, Inc. • Wholesale-groceries, general line • California
THIS AGREEMENT, effective June 27, 2016, is by and between 20/20 Produce Sales (hereinafter referred to as “Seller”), and MARKON COOPERATIVE, INC., a California corporation, at Post Office Box 2630, Salinas, CA 93902 (“MARKON”).
EXCHANGE AGREEMENT ANDExchange Agreement and Plan of Reorganization • January 31st, 2019 • 20/20 Global, Inc.
THIS EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION (the “Agreement”), is entered into effective as of March 14, 2014, by and among RM INVESTORS, INC., a Nevada corporation (“RMII”), 20/20 PRODUCE SALES, INC., an Idaho corporation (“Produce”) and the shareholders of 20/20 PRODUCE SALES, INC., named on the signature pages of this Agreement (collectively, the “Produce Shareholders”), based on the following:
SUPPLIER AUTHORIZATION AGREEMENT-PRODUCE U.S.Supplier Authorization Agreement - Produce • January 31st, 2019 • 20/20 Global, Inc. • Texas
This Supplier Authorization Agreement - Produce (“Agreement”) is made as of the date set forth on the signature page (“Effective Date”) by and between 20/20 Produce Sales, Inc., a “C” Corporation, with a principal place of business at 480 22nd St., Heyburn, Idaho 83336 (“Supplier”), and Sysco Merchandising and Supply Chain, Inc., a Delaware corporation with a principal place of business at 1390 Enclave Parkway, Houston, Texas 77077 (“SMS”).
ASSET SALE AND PURCHASE AGREEMENTAsset Sale and Purchase Agreement • December 5th, 2023 • Mycotopia Therapies, Inc. • Medicinal chemicals & botanical products • Florida
This Asset Sale and Purchase Agreement (“Agreement”) is made as of November 28, 2023, by and between MYCOTOPIA THERAPIES, INC., a Nevada corporation (“Company” or “Buyer”); and PHILON LABS, LLC., a Florida limited liability Company (“Seller”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 29th, 2020 • 20/20 Global, Inc. • Wholesale-groceries, general line • Nevada
THIS STOCK PURCHASE AGREEMENT (the “MYC SPA”) is made and becomes effective as of the date of last signature (the “Effective Date”), by and between 20/20 GLOBAL, INC., a Nevada corporation (“Purchaser”), and EHAVE INC., an Ontario corporation (“Seller”).
CHANGE OF CONTROL AND FUNDING AGREEMENTChange of Control and Funding Agreement • December 29th, 2020 • 20/20 Global, Inc. • Wholesale-groceries, general line • Nevada
THIS CHANGE OF CONTROL AND FUNDING AGREEMENT (this “Change of Control Agreement”), effective as of the date of the last signature (the “Effective Date”), is made by and among 20/20 GLOBAL, INC., a Nevada corporation (“20/20 Global”), EHAVE INC., an Ontario corporation (“Ehave”), MYCOTOPIA THERAPIES INC., a Florida corporation (“MYC”), MARK D. WILLIAMS, COLIN GIBSON, BENJAMIN KAPLAN, and MARK CROSKERY.
AMENDMENT TO ESCROW AGREEMENT AND DEFINITIVE AGREEMENTSEscrow Agreement • January 6th, 2021 • 20/20 Global, Inc. • Wholesale-groceries, general line
THIS AMENDMENT TO ESCROW AGREEMENT AND DEFINITIVE AGREEMENTS (this “Amendment”) is entered into effective this 4th day of January, 2021, by and among COLONIAL STOCK TRANSFER COMPANY, INC. (“Escrow Agent”), a Utah corporation located at 66 Exchange Place, Salt Lake City, Utah 84111; 20/20 GLOBAL, INC., a Nevada corporation (“20/20 Global”); MARK D. WILLIAMS, COLIN GIBSON, and THE ROBERT AND JOANNA WILLIAMS TRUST (the “20/20 Global Stockholders”) EHAVE INC., an Ontario corporation (“Ehave”); and MYCOTOPIA THERAPIES INC., a Florida corporation (“MYC”), based on the following:
INTELLECTUAL PROPERTY ASSIGNMENTIntellectual Property Assignment • December 5th, 2023 • Mycotopia Therapies, Inc. • Medicinal chemicals & botanical products
THIS ASSIGNMENT (this “Assignment”) is made as of November 14, 2023, between PHILON LABS, LLC., a Florida limited liability company (the “Assignor”) and MYCOTOPIA THERAPIES, INC., a Nevada corporation (the “Assignee”) (collectively, the “Parties”) with reference to that certain Asset Purchase Agreement, dated as of November 14, 2023, by and between Assignor and Assignee (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Purchase Agreement.
PRODUCE FIXED TERM PURCHASE AGREEMENTProduce Fixed Term Purchase Agreement • April 15th, 2019 • 20/20 Global, Inc. • Wholesale-groceries, general line • Texas
This Produce Fixed Term Purchase Agreement (this “Agreement”), is between Sysco Merchandising and Supply Chain Services, Inc. (“SMS”) and 2020 PRODUCE SALES (“Supplier”), effective as of October 15, 2018 (the “Effective Date”).
